Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  2011-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1248/BPB.34.1785PMID 22130231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Oncogene].

  2019cited by this paper
• Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

  2010cited by this paper
• Sunitinib in solid tumors

  2009cited by this paper
• Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

  2009cited by this paper
• VEGFR1 Tyrosine Kinase Signaling Promotes Lymphangiogenesis as Well as Angiogenesis Indirectly via Macrophage Recruitment

  2008cited by this paper
• Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

  2008cited by this paper
• Angiogenesis: an organizing principle for drug discovery?

  2007cited by this paper
• Proprotein convertases promote processing of VEGF‐D, a critical step for binding the angiogenic receptor VEGFR‐2

  2007cited by this paper
• Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions.

  2006cited by this paper
• Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.

  2006cited by this paper
• VEGF receptor signalling ? in control of vascular function

  2006cited by this paper
• Macrophages regulate the angiogenic switch in a mouse model of breast cancer.

  2006cited by this paper
• The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.

  2005cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

  2005cited by this paper
• The Adaptor Protein Shb Binds to Tyrosine 1175 in Vascular Endothelial Growth Factor (VEGF) Receptor-2 and Regulates VEGF-dependent Cellular Migration*

  2004cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38

  2004cited by this paper
• Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

  2004cited by this paper
• Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.

  2002cited by this paper
• VEGF-Trap: A VEGF blocker with potent antitumor effects

  2002cited by this paper
• Molecular mechanisms of lymphangiogenesis in health and disease.

  2002cited by this paper
• Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.

  2002cited by this paper
• Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

  2002cited by this paper
• Human vascular endothelial growth factor B: Characterization of recombinant isoforms and generation of neutralizing monoclonal antibodies

  2002cited by this paper
• Soluble Flt-1 (soluble VEGFR-1), a potent natural antiangiogenic molecule in mammals, is phylogenetically conserved in avians.

  2002cited by this paper
• Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

  2001cited by this paper
• A single autophosphorylation site on KDR/Flk‐1 is essential for VEGF‐A‐dependent activation of PLC‐γ and DNA synthesis in vascular endothelial cells

  2001cited by this paper
• Signalling via vascular endothelial growth factor receptor‐3 is sufficient for lymphangiogenesis in transgenic mice

  2001cited by this paper
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

  2001cited by this paper
• Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.

  2000cited by this paper
• Signaling via vascular endothelial growth factor receptors.

  1999cited by this paper
• Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer.

  1998cited by this paper
• Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

  1998cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

  1996cited by this paper
• Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

  1996cited by this paper
• Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Prognostic value of vascular endothelial growth factor expression in gastric carcinoma

  1996cited by this paper
• The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

  1996cited by this paper
• Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

  1995cited by this paper
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

  1993cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper
• The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

  1992cited by this paper
• A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.

  1991cited by this paper
• Identification of a new endothelial cell growth factor receptor tyrosine kinase.

  1991cited by this paper
• The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

  1991cited by this paper
• The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

  1991cited by this paper
• Br. J. Cancer

  1991cited by this paper
• Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

  1990cited by this paper
• Blood.

  1989cited by this paper
• Transplacental carcinogenesis by stilbestrol.

  1971cited by this paper
• Cáncer

  1939cited by this paper
• THE CANCER CELL

  1924cited by this paper

• Exploration of Novel Indole Compounds with Potential Activity Against Breast Cancer: Synthesis, Characterization and Anti-Cancer Activity Evaluation

  2026cites this paper
• Association of Proteinuria as an Observed Side Effect with a Worsening Rate of Renal Function Decline in Patients with Colorectal Cancer Treated with Bevacizumab.

  2025cites this paper
• Lymphatic malformation:Classification, Pathogenesis and Therapeutic Strategies.

  2025cites this paper
• Unveiling novel VEGFR-2 inhibitors: QSAR modeling, Molecular docking, MD and MM-GBSA calculations, pharmacokinetics profiling and DFT studies

  2025cites this paper
• Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: Therapeutic strategies and insights.

  2025cites this paper
• The Impact of Helminths on Colorectal Cancer: From Infections to the Isolation of Biotherapeutics

  2025cites this paper
• Case Report: Breast cancer in pregnancy with placental metastasis

  2025cites this paper
• Potential Use of Decorin in Preventing Cerebral Vasospasm through the Inhibition of Transforming Growth Factor-beta Activity: Insights from an Experimental Rabbit Subarachnoid Hemorrhage Model

  2025cites this paper
• Promotion of infected wound healing by black phosphorus-strontium via photothermal therapy

  2025cites this paper
• Sulfonamides a Promising Hit for Cancer Therapy Through VEGFR-2 Inhibition

  2025cites this paper
• Progress on the HIF-1α/VEGF/VEGFR2 signal pathway in hepatic alveolar echinococcosis

  2025cites this paper
• Different Intensities of Physical Activity and Risk of Male Genital Cancers: Exploring Potential Causal Relationships

  2025cites this paper
• Review the less explored correlation of VEGF signaling pathway with angiogenesis in multiple myeloma

  2025cites this paper
• Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodeling

  2025cites this paper
• Radiation-Induced Brain Injury with Special Reference to Astrocytes as a Therapeutic Target.

  2025cites this paper
• Design, synthesis, anticancer activity, and in silico computational studies of new imidazolone-based derivatives with potential multi-target kinase inhibitory activity.

  2025cites this paper
• Implications of Raftlin in different diseases: from molecular biology to diagnostic value.

  2025cites this paper
• Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice

  2024cites this paper
• Saccharomyces cerevisiae SC-2201 Attenuates AOM/DSS-Induced Colorectal Cancer by Modulating the Gut Microbiome and Blocking Proinflammatory Mediators

  2024cites this paper
• Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021-2023).

  2024cites this paper
• Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors: In vitro and in silico studies

  2024cites this paper
• Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study.

  2024cites this paper
• Remaining Issues Related to Serum Cytokines in Patients with Unresectable Hepatocellular Carcinoma Treated by Atezolizumab plus Bevacizumab Combination Treatment

  2024cites this paper
• Green synthesis, characterization, anti-cancer and antimicrobial activity of AuNPs extracted from Euphorbia antiquorum stem and flower: Experimental and theoretical calculations

  2024cites this paper
• New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity

  2024cites this paper
• Synthetic Antiangiogenic Vascular Endothelial Growth Factor—A Splice Variant Revascularizes Ischemic Muscle in Peripheral Artery Disease

  2024cites this paper
• Evaluation of the metabolic activity, angiogenic impacts, and GSK-3β signaling of the synthetic cannabinoid MMB-2201 on human cerebral microvascular endothelial cells

  2024cites this paper
• Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats

  2024cites this paper
• Effects of Atezolizumab plus Bevacizumab on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular Carcinoma

  2024cites this paper
• Assessment of the proliferative and angiogenic effects of the synthetic cannabinoid (R)-5-fluoro ADB on human cerebral microvascular endothelial cells

  2024cites this paper
• Integrating UPLC-Q-TOF-MS and Network Pharmacology to Explore the Potential Mechanisms of Paeonia lactiflora Pall. in the Treatment of Blood Stasis Syndrome

  2024cites this paper
• The supplementation of mannan oligosaccharide promotes the skin wound healing of juvenile turbot, Scophthalmus maximus.

  2024cites this paper
• Tivozanib-induced activation of the mitochondrial apoptotic pathway and suppression of epithelial-to-mesenchymal transition in oral squamous cell carcinoma.

  2024cites this paper
• Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive Review.

  2024cites this paper
• Recombinant hirudin suppresses angiogenesis of diffuse large B‐cell lymphoma through regulation of the PAR‐1‐VEGF

  2024cites this paper
• Intracavernosal mesenchymal stem cell therapy in ischaemic priapism: an experimental study

  2024cites this paper
• Sinensetin Inhibits Angiogenesis in Lung Adenocarcinoma via the miR-374c-5p/VEGF-A/VEGFR-2/AKT Axis

  2024cites this paper
• Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation

  2024cites this paper
• Radiation Synthesis and Characterization of pH-Responsive Sodium Alginate/Poly(acrylic acid) Nanogel Loaded with Ferulic Acid for Anticancer Drug Delivery

  2024cites this paper
• Redefining the significance of quinoline containing compounds as potent VEGFR-2 inhibitors for cancer therapy

  2024cites this paper
• Exercise, exerkines and exercise mimetic drugs: Molecular mechanisms and therapeutics.

  2024cites this paper
• Alternative Polyadenylation in Cancer: Molecular Mechanisms and Clinical Application.

  2024cites this paper
• Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior

  2024cites this paper
• Second-line Treatment Strategy in Unresectable Hepatocellular Carcinoma After First-line Atezolizumab Plus Bevacizumab

  2024cites this paper
• Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of Curcuma longa as Potential Lead Inhibitors of ERBB and VEGFR-2 for the Treatment of Colorectal Cancer

  2023cites this paper
• The Role of Eosinophil-Derived Neurotoxin and Vascular Endothelial Growth Factor in the Pathogenesis of Eosinophilic Asthma

  2023cites this paper
• Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics

  2023influential citation
• Repurposing of Some VEGFR-2 Inhibitors: In Silico Molecular Dynamics Simulation (at 200 ns), Docking Based on the SARS-CoV-2-Main-Protease Inhibitor N3

  2023cites this paper
• Light Chain Q166C Mutation Permits One‐step Site Specific Conjugation on Monoclonal Antibodies

  2023cites this paper
• Antineoplastic drugs inducing cardiac and vascular toxicity - An update.

  2023cites this paper
• A review on the effect of COX-2-mediated mechanisms on development and progression of gastric cancer induced by nicotine.

  2023cites this paper
• Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

  2023influential citation
• Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment

  2023cites this paper
• The importance of microvascular inflammation in ageing and age-related diseases: a position paper from the ESH working group on small arteries, section of microvascular inflammation

  2023cites this paper
• Electrochemical determination of vascular endothelial growth factor using functional metal-polymer nanocomposites

  2023cites this paper
• Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance

  2023cites this paper
• An Online CMC–LC/MS Method for Screening Angiogenesis Promoting Components in Yiqi Fumai Lyophilization Injection (YQFM)

  2023cites this paper
• The Mechanisms of Ferroptosis Under Hypoxia

  2023cites this paper
• Pooled analysis of three pharmacokinetic studies comparing biosimilar MB02 and reference bevacizumab

  2023cites this paper
• Exploration of thiazolidine‐2,4‐diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations

  2022cites this paper
• Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives

  2022cites this paper
• Nanogel-mediated drug delivery system for anticancer agent: pH stimuli responsive poly(ethylene glycol/acrylic acid) nanogel prepared by gamma irradiation.

  2022cites this paper
• Inflammatory-associated apoptotic markers: are they the culprit to rheumatoid arthritis pain?

  2022cites this paper
• Design, synthesis, in silico docking, ADMET and anticancer evaluations of thiazolidine-2,4-diones bearing heterocyclic rings as dual VEGFR-2/EGFRT790M tyrosine kinase inhibitors

  2022cites this paper
• In Vivo Imaging of Neo-angiogenesis of Transplanted Metastases in Subrenal Capsule Assay Induced Rat Model

  2022cites this paper
• Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer.

  2022cites this paper
• Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer

  2022cites this paper
• Targeted Codelivery of Prodigiosin and Simvastatin Using Smart BioMOF: Functionalization by Recombinant Anti-VEGFR1 scFv

  2022cites this paper
• Structure Based Design of Some Novel 3-Methylquinoxaline Derivatives Through Molecular Docking and Pharmacokinetics Studies as Novel VEGFR-2 Inhibitors

  2022cites this paper
• In silico molecular docking, dynamics simulation and repurposing of some VEGFR-2 inhibitors based on the SARS-CoV-2-main-protease inhibitor N3

  2022cites this paper
• Maternal Fatty Acid Metabolism in Pregnancy and Its Consequences in the Feto-Placental Development

  2022cites this paper
• Molecular methods for increasing the effectiveness of ovarian cancer treatment: a systematic review.

  2022cites this paper
• Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists

  2022cites this paper
• Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers

  2021cites this paper
• A randomized, single-dose, pharmacokinetic equivalence study comparing MB02 (proposed biosimilar) and reference bevacizumab in healthy Japanese male volunteers

  2021cites this paper
• Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers.

  2021cites this paper
• A randomized, double blind, single dose, comparative study of the pharmacokinetics, safety and immunogenicity of MB02 (bevacizumab biosimilar) and reference bevacizumab in healthy male volunteers

  2021cites this paper
• Anti-VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E-cadherin/β-catenin signaling axis in experimental asthma models

  2021cites this paper
• Expression levels of VEGF-C and VEGFR-3 in renal cell carcinoma and their association with lymph node metastasis

  2021cites this paper
• Regeneration in Spinal Disease: Therapeutic Role of Hypoxia-Inducible Factor-1 Alpha in Regeneration of Degenerative Intervertebral Disc

  2021cites this paper
• Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors

  2021cites this paper
• Effects of I-125 seeds combined with anlotinib on tumor growth and bone metabolism in A549 tumor-bearing mice

  2021influential citation
• Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs

  2021cites this paper
• Ramucirumab-related Oral Pyogenic Granuloma: A Report of Two Cases

  2021influential citation
• Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy

  2021cites this paper
• Diabetic nephropathy with and without retinopathy: comparison between urine and serum vascular endothelial growth factor

  2021cites this paper
• Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.

  2021cites this paper
• Mitigation of acute radiation-induced brain injury in a mouse model using anlotinib.

  2021cites this paper
• 1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies

  2021cites this paper
• Anti-angiogenic peptides application in cancer therapy; a review

  2021cites this paper
• Effect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris

  2020cites this paper
• A Meta-Analysis of the Association Between the VEGF +936C>T Gene Polymorphism and Digestive System Cancer Susceptibility

  2020cites this paper
• Effects of tributyltin on gonad and brood pouch development of male pregnant lined seahorse (Hippocampus erectus) at environmentally relevant concentrations.

  2020cites this paper
• Case Study on Receptor Tyrosine Kinases EGFR, VEGFR, and PDGFR

  2020cites this paper
• Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.

  2020cites this paper
• Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2,4‐dichloro)benzylidene]thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors

  2020cites this paper
• Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA

  2020cites this paper
• Lack of association between VEGF -2578C/A polymorphism and risk of colorectal cancer in an Iranian population

  2020cites this paper
• miR-377-5p inhibits proliferation and invasion of hepatocellular carcinoma HepG2 cells by down-regulating HIF-1α and related VEGF signaling pathway

  2020cites this paper
• 5‐(4‐Methoxybenzylidene)thiazolidine‐2,4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations

  2020cites this paper